Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.096
Delayed Data
As of Apr 18
 +0.0013 / +1.37%
Today’s Change
0.06
Today|||52-Week Range
0.25
+4.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$83.8M

Company Description

Elite Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology, as it relates to abuse resistant products. Its strategy includes off-patent drug products for life cycle management and developing generic versions of controlled-release drug products. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Contact Information

Elite Pharmaceuticals, Inc.
165 Ludlow Avenue
Northvale New Jersey 07647
P:(201) 750-2646
Investor Relations:
(518) 398-6222

Employees

Shareholders

Individual stakeholders21.81%
Mutual fund holders0.13%
Other institutional0.01%

Top Executives

Nasrat A. HakimChairman, President & Chief Executive Officer
Douglas PlasscheExecutive Vice President-Operations
Carter J. WardChief Financial Officer, Secretary & Treasurer
Christopher C. DickHead-Development
Dianne WillVP-Investor Relations & Corporate Communications